CXCL8 plays a role in angiogenesis, and IL-1β enhances tumor inflammation, activates the β-catenin signaling pathway and induces EMT in breast cancer cells in addition to the expression of PTGS2. This evidence concerns the gene CXCL8 and breast cancer.